Nemus Bioscience (NMUS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
Want to compare other data? Select Fields| Symbol | NMUS | AMGN | GILD | CELG | VRTX |
| Company | Nemus Bioscience | Amgen Inc | Gilead Sciences Inc | Celgene Corp | Vertex Pharmaceutic |
| Price Information | |||||
| Exchange | OTC US | NASDAQ | NASDAQ | NASDAQ | NASDAQ |
| Open | 0.7185 | 250.25 | 75.11 | 108.01 | 295.52 |
| High | 0.7189 | 253.83 | 75.84 | 108.59 | 297.79 |
| Low | 0.6000 | 248.84 | 73.95 | 107.27 | 290.05 |
| Last | 0.6500 | 251.66 | 74.71 | 108.24 | 295.40 |
| Change | -0.0684 | +0.07 | -0.90 | +0.11 | -0.52 |
| % Change | -9.52% | +0.03% | -1.19% | +0.10% | -0.18% |
| Volume | 1,004,500 | 1,739,500 | 5,199,700 | 191,230,500 | 1,107,000 |
| 20-Day Average Volume | 494,515 | 2,904,860 | 8,322,445 | 16,188,930 | 1,666,495 |
| Previous Close | 0.7184 | 251.59 | 75.61 | 108.13 | 295.92 |
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical |
| Has Options | No | Yes | Yes | No | Yes |
| Technicals | |||||
| 20-Day Moving Average | 0.5046 | 237.11 | 75.20 | 108.17 | 286.13 |
| 20-Day Raw Stochastic | 72.67% | 73.96% | 45.98% | 63.25% | 75.64% |
| 20-Day Relative Strength | 63.72% | 61.54% | 47.80% | 64.69% | 57.80% |
| Weighted Alpha | +34.72 | +40.90 | +13.00 | +46.30 | +70.90 |
| Today's Opinion | 100% Buy | 88% Buy | 8% Buy | 100% Buy | 100% Buy |
| Previous Opinion | 100% Buy | 88% Buy | 40% Buy | 100% Buy | 100% Buy |
| Last Month's Opinion | 88% Buy | 56% Buy | 72% Buy | 100% Buy | 80% Buy |
| Performance | |||||
| 5-Days | |||||
| %Chg | +40.54% since 03/15/19 | -1.36% since 07/01/20 | -1.77% since 07/01/20 | -1.97% since 11/13/19 | +3.19% since 07/01/20 |
| Low | 0.4700 on 03/18/19 | 248.84 on 07/09/20 | 73.95 on 07/09/20 | 107.27 on 11/20/19 | 287.45 on 07/02/20 |
| High | 0.7440 on 03/21/19 | 264.97 on 07/06/20 | 77.66 on 07/06/20 | 110.53 on 11/14/19 | 306.08 on 07/07/20 |
| 1-Month | |||||
| %Chg | +31.31% since 02/22/19 | +11.90% since 06/09/20 | -3.71% since 06/09/20 | +5.14% since 10/18/19 | +9.06% since 06/09/20 |
| Low | 0.4000 on 03/11/19 | 213.86 on 06/15/20 | 71.91 on 06/12/20 | 102.40 on 10/21/19 | 262.24 on 06/15/20 |
| High | 0.7440 on 03/21/19 | 264.97 on 07/06/20 | 78.39 on 06/10/20 | 110.70 on 11/13/19 | 306.08 on 07/07/20 |
| 3-Month | |||||
| %Chg | +62.54% since 12/21/18 | +15.33% since 04/09/20 | +1.63% since 04/09/20 | +13.63% since 08/20/19 | +19.78% since 04/09/20 |
| Low | 0.3000 on 01/31/19 | 213.86 on 06/15/20 | 71.91 on 06/12/20 | 93.41 on 08/23/19 | 243.80 on 04/13/20 |
| High | 0.7440 on 03/21/19 | 264.97 on 07/06/20 | 85.79 on 04/17/20 | 110.70 on 11/13/19 | 306.08 on 07/07/20 |
| 6-Month | |||||
| %Chg | +120.34% since 09/21/18 | +5.33% since 01/09/20 | +13.47% since 01/09/20 | +14.14% since 05/20/19 | +28.29% since 01/09/20 |
| Low | 0.0500 on 10/31/18 | 177.05 on 03/23/20 | 62.23 on 01/21/20 | 89.08 on 07/23/19 | 197.47 on 03/18/20 |
| High | 0.7440 on 03/21/19 | 264.97 on 07/06/20 | 85.97 on 03/19/20 | 110.70 on 11/13/19 | 306.08 on 07/07/20 |
| Key Statistics | |||||
| Market Capitalization, $K | 87,040 | 148,038,240 | 93,714,208 | 77,035,920 | 76,590,424 |
| Shares Outstanding, K | 133,908 | 588,247 | 1,254,373 | 711,714 | 259,277 |
| Annual Sales | 0 | 23,362,000,000 | 22,449,000,000 | 15,281,000,000 | 4,162,820,000 |
| Annual Net Income | -19,190,000 | 7,842,000,000 | 5,386,000,000 | 4,046,000,000 | 1,176,810,000 |
| Last Quarter Sales | 0 | 6,161,000,000 | 5,548,000,000 | 4,520,000,000 | 1,515,110,000 |
| Last Quarter Net Income | -6,220,000 | 1,825,000,000 | 1,551,000,000 | 1,691,000,000 | 602,750,000 |
| 60-Month Beta | -0.04 | 0.94 | 0.70 | 1.41 | 0.94 |
| Per-Share Information | |||||
| Most Recent Earnings | N/A | 4.17 on 04/30/20 | 1.68 on 04/30/20 | 2.99 on 10/31/19 | 2.56 on 04/29/20 |
| Latest Earnings Date | 10/05/18 | 07/28/20 | 08/04/20 | 10/31/19 | 07/29/20 |
| Most Recent Dividend | N/A | 1.600 on 05/15/20 | 0.680 on 06/11/20 | N/A | N/A |
| Next Ex-Dividends Date | N/A | 05/15/20 | 06/11/20 | N/A | N/A |
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 16.29 | 12.29 | 10.99 | 52.75 |
